Melhus H, Michaelsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.
Ann Intern Med.
1998;129:770 - 778.
Chao D, Espeland MA, Farmer D, et al. Effect of voluntary weight loss on bone mineral density in older overweight women.
J Am Geriatr Soc.
2000;48:753 - 759.
Reid IR. The roles of calcium and vitamin D in the prevention of osteoporosis.
Endocrinol Metab Clin North Am. 1998;27:389 - 398.
Cumming RG. Calcium intake and bone mass: a quantitative review of the evidence.
Calcif Tissue Int. 1990;47:194 - 201.
Dawson-Hughes B, Dallal GE, Krall EA, et al. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.
N Engl J Med. 1990;323:878 - 883.
Peacock M, Liu G, Carey M, et al. Effect of calcium or 25OH vitamin D
3
dietary supplementation on bone loss at the hip in men and women over the age of 60.
J Clin Endocrinol Metab.
2000;85:3011 - 3019.
Prince RL. Diet and the prevention of osteoporotic fractures.
N Engl J Med. 1997;337:701 - 702.
Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D
3
supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1996;125:961 - 968.
Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis.
Cochrane Database Syst Rev.
2000;(2):CD000952.
Dawson-Hughes B, Harris SS, Krall EA, et al. Effect of withdrawal of calcium and vitamin D supplements on bone mass in elderly men and women.
Am J Clin Nutr.
2000;72:745 - 750.
Saltman PD, Strause LG. The role of trace minerals in osteoporosis.
J Am Coll Nutr. 1993;12:384 - 389.
Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals.
J Nutr. 1994;124:1060 - 1064.
Kruger MC, Coetzer H, de Winter R, et al. Calcium, gamma-linolenic acid and eicosapentaenoic acid supplementation in senile osteoporosis.
Aging (Milano).
1998;10:385 - 394.
Bassey EJ, Littlewood JJ, Rothwell MC, et al. Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre- and postmenopausal women: two randomized controlled trials of Efacal® v. calcium alone.
Br J Nutr.
2000;83:629 - 635.
Agnusdei D, Crepaldi G, Isaia G, et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Calcif Tissue Int. 1997;61:142 - 147.
Gennari C, Adami S, Agnusdei D, et al. Effect of chronic treatment with ipriflavone in postmenopausal women with low bone mass.
Calcif Tissue Int. 1997;61(suppl 1):S19 - S22.
Valente M, Bufalino L, Castiglione GN, et al. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass.
Calcif Tissue Int. 1994;54:377 - 380.
Kovacs AB. Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis.
Agents Actions. 1994;41:86 - 87.
Adami S, Bufalino L, Cervetti R, et al. Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years.
Osteoporos Int. 1997;7:119 - 125.
Agnusdei D, Bufalino L, et al. Efficacy of ipriflavone in established osteoporosis and long-term safety.
Calcif Tissue Int. 1997;61(suppl 1):S23 - S27.
Agnusdei D, Zacchei F, Bigazzi S, et al. Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
Drugs Exp Clin Res.
1989;15:97 - 104.
Maugeri D, Panebianco P, Russo MS, et al. Ipriflavone-treatment of senile osteoporosis: results of a multicenter, double-blind clinical trial of 2 years.
Arch Gerontol Geriatr.
1994;19:253 - 263.
Passeri M, Biondi M, Costi D, et al. Effects of 2-year therapy with ipriflavone in elderly women with established osteoporosis.
Ital J Mineral Electrolyte Metab.
1995;9:137 - 144.
Agnusdei D, Adami S, Cervetti R, et al. Effects of ipriflavone on bone mass and calcium metabolism in postmenopausal osteoporosis.
Bone Miner.
1992;19 (suppl 1):S43 - S48.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482 - 1488.
Melis GB, Paoletti AM, Cagnacci A. Ipriflavone prevents bone loss in postmenopausal women.
Menopause. 1996;3:27 - 32.
Agnusdei D, Crepaldi G, Isaia G, et al. A double blind, placebo-controlled trial of ipriflavone for prevention of postmenopausal spinal bone loss.
Calcif Tissue Int. 1997;61:142 - 147.
Alexandersen P, Toussaint A, Christiansen C, et al. Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
JAMA.
2001;285:1482 - 1488.
Gambacciani M, Cappagli B, Piaggesi L, et al. Ipriflavone prevents the loss of bone mass in pharmacological menopause produced by GnRH-agonists.
Calcif Tissue Int. 1997;61(suppl 1):S15 - S18.
Yamazaki I, Shino A, Shimizu Y, et al. Effect of ipriflavone on glucocorticoid-induced osteoporosis in rats.
Life Science
1986;38:951 - 958.
Gambacciani M, Spinetti A, Piaggesi L, et al. Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists.
Bone Miner.
1994;26:19 - 26.
Melis GB, Paoletti AM, Bartolini R, et al. Ipriflavone and low doses of estrogens in the prevention of bone mineral loss in climacterium.
Bone Miner. 1992;19(suppl 1):S49 - S56.
Nozaki M, Hashimoto K, Inoue Y, et al. Treatment of bone loss in oophorectomized women with a combination of ipriflavone and conjugated equine estrogen.
Int J Gynaecol Obstet. 1998;62:69 - 75.
Maugeri D, Panebianco P, Russo MS, et al. Ipriflavone-treatment of senile osteoporosis: results of a multicenter double-blind clinical trial of 2 years.
Arch Gerontol Geriatr.
1994;19:253 - 263.
Moscarini M, Patacchiola F, Spacca G, et al. New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone.
Gynecol Endocrinol.
1994;8:203 - 207.
Scali G, Mansanti P, Zurlo A, et al. Analgesic effect of ipriflavone versus sCalcitonin in the treatment of osteoporotic vertebral pain.
Curr Ther Res.
1991;49:1004 - 1010.
Potter SM, Baum JA, Teng H, et al. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenopausal women.
Am J Clin Nutr.
1998;68(6 suppl):1375S - 1379S.
Alekel DL, St. Germain A, Peterson CT, et al. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women.
Am J Clin Nutr.
2000;72:844 - 852.
Harrison E, Adjei A, Ameho C, et al. The effect of soybean protein on bone loss in a rat model of postmenopausal osteoporosis.
J Nutr Sci Vitaminol (Tokyo).
1998;44:257 - 268.
Fanti O, Faugere MC, Gang Z, et al. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism [abstract].
Am J Clin Nutr.
1998;68(suppl):1517S - 1518S.
Arjmandi BH, Alekel L, Hollis BW, et al. Dietary soybean protein prevents bone loss in an ovariectomized rat model of osteoporosis.
J Nutr.
1996;126:161 - 167.
Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Osteoporos Int.
1998;8:274 - 281.
Anderson JJ, Ambrose WW, Garner SC. Biphasic effects of genistein on bone tissue in the ovariectomized, lactating rat model.
Proc Soc Exp Biol Med.
1998;217:345 - 350.
Malochet S, Picherit C, Horcajada-Molteni MN, et al. Do endurance training and soy isoflavones exhibit additive effects on ovariectomy-induced osteopenia in the rat? [abstract].
J Bone Miner Res. 1999;14(suppl 1):S536.
Arjmandi BH, Birnbaum R, Goyal NV, et al. Bone-sparing effect of soy protein in ovarian hormone-deficient rats is related to its isoflavone content.
Am J Clin Nutr.
1998;68(suppl):1364S - 1368S.
Lees CJ, Ginn TA. Soy protein isolate diet does not prevent increased cortical bone turnover in ovariectomized macaques.
Calcif Tissue Int.
1998;62:557 - 558.
Jayo MJ. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys [abstract].
J Bone Miner Res.
1996;11(suppl 1):S228.
Gallagher JC, Rafferty K, Haynatzka V, et al. The effect of soy protein on bone metabolism [abstract].
J Nutr.
2000;130:666S - 669S.
Fanti O, Faugere MC, Gang Z, et al. Systematic administration of genistein partially prevents bone loss in ovariectomized rats in a nonestrogen-like mechanism [abstract].
Am J Clin Nutr.
1998;68(suppl):1517S - 1518S.
Fanti P, Monier-Faugere MC, Geng Z, et al. The phytoestrogen genistein reduces bone loss in short-term ovariectomized rats.
Osteoporos Int.
1998;8:274 - 281.
Feskanich D, Weber P, Willett WC, et al. Vitamin K intake and hip fractures in women: a prospective study.
Am J Clin Nutr. 1999;69:74 - 79.
Kanai T, Takagi T, Masuhiro K, et al. Serum vitamin K level and bone mineral density in post-menopausal women.
Int J Gynaecol Obstet. 1997;56:25 - 30.
Hart JP, Shearer MJ, Klenerman L, et al. Electrochemical detection of depressed circulating levels of vitamin K1 in osteoporosis
. J Clin Endocrinol Metab . 1985;60:1268 - 1269.
Bitensky L, Hart JP, Catterall A, et al. Circulating vitamin K levels in patients with fractures.
J Bone Joint Surg. 1988;70-B:663 - 664.
Hodges SJ, Pilkington MJ, Stamp TC, et al. Depressed levels of circulating menaquinones in patients with osteoporotic fractures of the spine and femoral neck.
Bone. 1991;12:387 - 389.
Jie KS, Gijsbers BL, Knapen MH, et al. Effects of vitamin K and oral anticoagulants on urinary calcium excretion.
Br J Haematol. 1993;83:100 - 104.
Knapen MH, Hamulyak K, Vermeer C. The effect of vitamin K supplementation on circulating osteocalcin (bone Gla protein) and urinary calcium excretion.
Ann Intern Med. 1989;111:1001 - 1005.
Tomita A, Fujita T, Takatsuki K, et al. 47 Ca kinetic study and vitamin K 2 in postmenopausal osteoporosis [in Japanese].
Horumon To Rinsho. 1971;19:731 - 736.
Orimo H, Shiraki M, Fujita T, et al. Clinical evaluation of menatetrenone in the treatment of involutional osteoporosis - a double-blind multicenter comparative study with 1 alpha-hydroxy vitamin D3 [abstract].
J Bone Miner Res. 1992;7(suppl 1):S122.
Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women.
Am J Clin Nutr.
2000;71:1201 - 1208.
Baulieu EE, Thomas G, Legrain S, et al. Dehydroepiandrosterone (DHEA), DHEA sulfate, and aging: contribution of the DHEAge Study to a sociobiomedical issue.
Proc Natl Acad Sci U S A.
2000;97:4279 - 4284.
Labrie F, Diamond P, Cusan L, et al. Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women.
J Clin Endocrinol Metab. 1997;82:3498 - 3505.
van Vollenhoven RF, Park JL, Genovese MC, et al. A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.
Lupus.
1999;8:181 - 187.
Greendale GA, Edelstein S, Barrett-Connor E. Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study.
J Bone Miner Res.
1997;12:1833 - 1843.
Hegarty V, May H, Khaw K. Tea drinking and bone mineral density in older women.
Am J Clin Nutr.
2000;71:1003 - 1007.
Nielsen FH, Hunt CD, Mullen LM, et al. Effect of dietary boron on mineral, estrogen and testosterone metabolism in postmenopausal women.
FASEB J. 1987;1:394 - 397.
Naghii MR, Samman S. The effect of boron supplementation on its urinary excretion and selected cardiovascular risk factors in healthy male subjects.
Biol Trace Elem Res. 1997;56:273 - 286.
Nielsen FH, Hunt CD, Mullen LM, et al. Effect of dietary boron on mineral, estrogen and testosterone metabolism in postmenopausal women.
FASEB J. 1987;1:394 - 397.
Munger RG, Cerhan JR, Chiu BC. Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women.
Am J Clin Nutr.
1999;69:147 - 152.
Schurch MA, Rizzoli R, Slosman D, et al. Protein supplements increase serum insulin-like growth factor-I levels and attenuate proximal femur bone loss in patients with recent hip fracture. A randomized, double-blind, placebo-controlled trial.
Ann Intern Med.
1998;128:801 - 809.
Prior JC. Progesterone as a bone-trophic hormone.
Endocr Rev. 1990;11:386 - 398.
Verhaar HJ, Damen CA, Duursma SA, et al. A comparison of the action of progestins and estrogen on the growth and differentiation of normal adult human osteoblast-like cells in vitro.
Bone. 1994;15:307 - 311.
Lee JR. Is natural progesterone the missing link in osteoporosis prevention and treatment?
Med Hypotheses. 1991;35:316 - 318.
Lee JR. Osteoporosis reversal with transdermal progesterone.
Lancet. 1990;336:1327.
Lee JR. Osteoporosis reversal, the role of progesterone.
Int Clin Nutr Rev. 1990;10:384 - 391.
Leonetti HB, Longo S, Anasti JN. Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.
Obstet Gynecol.
1999;94:225 - 228.
Writing Group for the PEPI Trial. Effects of hormone replacement therapy on endometrial histology in postmenopausal women: the postmenopausal estrogen/progestin interventions (PEPI) trial.
JAMA.
1996;275:370 - 375.
Minaguchi H, Uemura T, Shirasu K, et al. Effect of estriol on bone loss in postmenopausal Japanese women: a multicenter prospective open study.
J Obstet Gynaecol Res. 1996;22:259 - 265.
Itoi H, Minakami H, Sato I. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen, 1-alpha-hydroxyvitamin D3 and calcium lactate on vertebral bone loss in early menopausal women.
Maturitas. 1997;28:11 - 17.
Hayashi T, Ito I, Kano H, et al. Estriol (E3) replacement improves endothelial function and bone mineral density in very elderly women.
J Gerontol A Biol Sci Med Sci. 2000;55:B183 - B190.
Holland EF, Leather AT, Studd JW. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants.
Br J Obstet Gynaecol. 1995;102:238 - 242.
Nozaki M, Hashimoto K, Inoue Y, et al. Usefulness of estriol for the treatment of bone loss in postmenopausal women [in Japanese; English abstract].
Nippon Sanka Fujinka Gakkai Zasshi. 1996;48:83 - 88.
Lindsay R, Hart DM, Maclean A, et al. Bone loss during oestriol therapy in postmenopausal women.
Maturitas. 1979;1:279 - 285.
Granberg S, Ylostalo P, Wikland M, et al. Endometrial sonographic and histologic findings in women with and without hormonal replacement therapy suffering from postmenopausal bleeding.
Maturitas. 1997;27:35 - 40.
Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study.
Lancet. 1999;353:1824 - 1828.
Montoneri C, Zarbo G, Garofalo A, et al. Effects of estriol administration on human postmenopausal endometrium.
Clin Exp Obstet Gynecol. 1987;14:178 - 181.
Takahashi K, Manabe A, Okada M, et al. Efficacy and safety of oral estriol for managing postmenopausal symptoms.
Maturitas. 2000;34:169 - 177.
Lippman M, Monaco ME, Bolan G. Effects of estrone, estradiol and estriol on hormone-responsive human breast cancer in long-term tissue culture.
Cancer Res. 1977;37:1901 - 1907.
Cashman KD, Baker A, Ginty F, et al. No effect of copper supplementation on biochemical markers of bone metabolism in healthy young adult females despite apparently improved copper status.
Eur J Clin Nutr.
2001;55:525 - 531.
Dawson-Hughes B, Harris S. Calcium intake influences the association of protein intake with rates of bone loss in elderly men and women.
Am J Clin Nutr.
2002;75:773-779.
Kahn AJ, Haloran B. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men.
J Clin Endocrinol Metab.
2002;87:1544-1549.
Wuttke W. Abstracts P3-333, P3-317.84th annual meeting of The Endocrine Society, June 21, 2002.
Pfeifer M, Begerow B, Minne H, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women.
J Bone Miner Res.
2000;15:1113-1118.
Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people.
Am J Clin Nutr.
2002;75:611-615.
Messina M, Gardner C, Barnes S. Gaining insight into the health effects of soy but a long way still to go: commentary on the fourth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease.
J Nutr. 2002;132:547S.
Morabito N, Crisafulli A, Vergara C, et al. Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: a randomized double-blind, placebo-controlled study.
J Bone Miner Res.
2002;17:1904-1912.
Gordon CM, Grace E, Emans SJ. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: a randomized trial.
J Clin Endocrinol Metab.
2002;87:4935-4941.
Beattie JH, Peace HS. The influence of a low boron - diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women.
Br J Nutr. 1993;69:871 - 884.
Michaelsson K, Lithell H, Vessby B, et al. Serum retinol levels and the risk of fracture.
N Engl J Med. 2003;348:287 - 294.
Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial.
BMJ. 2003;326:469.
Braam LA, Knapen MH, Geusens P, et al. Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.
Calcif Tissue Int. 2003;3[epub ahead of print].
Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.
J Bone Miner Res. 2003;18:343 - 351.
Lee A, et al. A Randomized, Controlled Trial of Quadriceps Resistance Exercise and Vitamin D in Frail Older People: The Frailty Interventions Trial in Elderly Subjects (FITNESS).
J Am Geriatr Soc. 2003;51:291 - 299.
Jones G, Dwyer T, Hynes K, et al. A randomized controlled trial of phytoestrogen supplementation, growth and bone turnover in adolescent males.
Eur J Clin Nutr. 2003;57:324 - 327.
Reginster JY, Meunier PJ. Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies.
Osteoporos Int. 2003. [epub ahead of print]
Marie PJ. Optimizing bone metabolism in osteoporosis: insight into the pharmacologic profile of strontium ranelate.
Osteoporos Int. 2003;14:9 - 12.
Boivin G, Meunier PJ. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
Osteoporos Int. 2003;14(Suppl 3):19 - 24.
Skov A, Haulrik N, Toubro S, et al. Effect of protein intake on bone mineralization during weight loss: a 6-month trial.
Obes. Res. 2002;10:432 - 438.
Promislow J, Goodman-Gruen D, Slymen D, et al., Protein consumption and bone mineral density in the elderly: the Rancho Bernardo study.
Am J Epidemiol. 2002;155:636 - 644.
Latham NK, Anderson CS, Reid IR. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review.
J Am Geriatr Soc. 2003;51:1219 - 1226.
Último revisado julio 2012 por EBSCO CAM Review Board
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.
Copyright © EBSCO Publishing. All rights reserved.